New precautions added for GLP-1 drugs as reports of mood changes and contraceptive concerns emerge in Australia.

Australia's Therapeutic Goods Administration has issued new safety warnings about mental health risks and contraception ...

The EMA (European Medicines Agency), FDA and WHO identified semaglutide suicidal thought reports, exceeding those of other ...

Australia’s drug regulator has ­issued multiple safety warnings including for potential suicidal ideation associated with the use of some of the most popular GLP-1 medications.

The most common side effects of GLP-1 medicines are related to digestion: nausea, vomiting, diarrhoea, indigestion, stomach ...

While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...

Ideal weight loss is a never-ending wish for everyone's dreams, but it gets way too slow if done in a healthy way.People ...

Australia’s TGA has issued updated safety warnings for GLP-1 drugs like Ozempic and Mounjaro, highlighting mental-health ...

Australia’s regulator has issued warnings about the risk of suicidal thoughts and lower effectiveness of contraceptives in ...

The Therapeutic Goods Administration issued a new warning for GLP-1 receptor agonists, including Ozempic and Mounjaro, on ...

Australia's medicines regulator issues a safety warning over the potential risk of suicidal thoughts and behaviours when ...

For those who have been prescribed weight loss or diabetes management drugs, like Ozempic, a new warning has been issued.